Research Article| Volume 20, SUPPLEMENT 3, C20-C25, 1998

The US Food and Drug Administration Modernization Act of 1997: impact on consumers

  • Linda F. Golodner
    Address correspondence to: Linda F. Golodner, President, National Consumers League, 1701 K Street, NW, Suite 1200, Washington, DC 20006.
    National Consumers League, Washington, DC U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.


      This paper provides a consumer's perspective on an important issue that has a profound impact on all of us: the US Food and Drug Administration (FDA) Modernization Act of 1997. In addition, it provides some background information on the National Consumers League, an organization that promotes consumer safety and protection with the FDA and its predecessors.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Marwick C
        Implementing the FDA Modernization Act.
        JAMA. 1998; 279: 815-816
        • Roche Laboratories
        Drug prescribing information.
        in: 52nd ed. Physicians' Desk Reference. Medical Economics Co, Montvale, NJ1998: 2485
      1. Patient testing and labeling strengthened for Rezulin.
        FDA Talk Paper. 1 December 1997;
        • Marwick C
        Concern expressed about FDA reform legislation.
        JAMA. 1997; 278: 459
        • Lazarou J
        • Pomeranz BH
        • Corey PN
        Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies.
        JAMA. 1998; 279: 1200-1205